|
Market Closed -
Nasdaq
00:00:00 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 15.92 USD | -0.47% |
|
+0.16% | +100.06% |
| 10-27 | Alert from law firm tagged to Personalis withdrawn | RE |
| 10-21 | Personalis, Inc. Announces NeXT Personal Ultrasensitive Circulating Tumor DNA Test Presentations at ESMO Congress 2026 | CI |
Company Valuation: Personalis, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 639.1 | 91.02 | 103 | 410.5 | 706.9 | 1,701 | - | - |
| Change | - | -85.76% | 13.12% | 298.67% | 72.2% | 140.6% | - | - |
| Enterprise Value (EV) | 406.9 | -76.63 | 37.13 | 260.4 | 498.8 | 1,701 | 1,701 | 1,701 |
| Change | - | -118.83% | 148.46% | 601.14% | 91.57% | 240.98% | 0% | 0% |
| P/E | -9.58x | -0.8x | -0.93x | -4.22x | -8.75x | -14.7x | -16.5x | -21.5x |
| PBR | 2.07x | 0.42x | 0.82x | 2.43x | 3.12x | - | - | - |
| PEG | - | -0x | 0.1x | 0.1x | 0.3x | -0.8x | 1.5x | 0.9x |
| Capitalization / Revenue | 7.47x | 1.4x | 1.4x | 4.85x | 10.1x | 20.2x | 15.4x | 11.6x |
| EV / Revenue | 0x | -0x | 0x | 0x | 0x | 20.2x | 15.4x | 11.6x |
| EV / EBITDA | -0x | 0x | -0x | -0x | -0x | -14.7x | -17.6x | -22.5x |
| EV / EBIT | -0x | 0x | -0x | -0x | -0x | -14.1x | -15.5x | -19.6x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.49 | -2.48 | -2.25 | -1.37 | -0.91 | -1.082 | -0.9667 | -0.74 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 85.49 | 65.05 | 73.48 | 84.61 | 69.65 | 84.34 | 110.1 | 146.7 |
| EBITDA 1 | -59.34 | -107.1 | -98.64 | -57.33 | -78.01 | -115.6 | -96.38 | -75.5 |
| EBIT 1 | -65.35 | -115.5 | -109.9 | -68.27 | -88.06 | -120.4 | -109.5 | -86.6 |
| Net income 1 | -65.23 | -113.3 | -108.3 | -81.28 | -81.27 | -114.1 | -103.1 | -80.6 |
| Net Debt | -232.2 | -167.7 | -65.83 | -150.1 | -208.1 | - | - | - |
| Reference price 2 | 14.27 | 1.98 | 2.10 | 5.78 | 7.96 | 15.92 | 15.92 | 15.92 |
| Nbr of stocks (in thousands) | 44,784 | 45,971 | 49,031 | 71,020 | 88,804 | 106,800 | - | - |
| Announcement Date | 24/02/22 | 23/02/23 | 28/02/24 | 27/02/25 | 26/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.78x | - | - | - | 1.71B | |
| 13.09x | 0.4x | 8.36x | 2.96% | 115B | |
| 15.31x | 1.91x | 9.5x | 0.67% | 100B | |
| -295.7x | 20.65x | -349.08x | -.--% | 61.18B | |
| 14.04x | 1.54x | 9.29x | 2.52% | 29.09B | |
| 25.42x | 2.33x | 13.19x | 0.81% | 29.25B | |
| 23.79x | 2.65x | 13.45x | 1.35% | 27.02B | |
| 8.15x | 1.46x | 6.61x | -.--% | 21.62B | |
| 30.84x | 5.5x | 22.34x | 2.27% | 20.81B | |
| 30.61x | 2.86x | 12.86x | 1.47% | 16.97B | |
| Average | -14.92x | 4.36x | -28.17x | 1.34% | 42.3B | |
| Weighted average by Cap. | -28.23x | 4.46x | -41.77x | 1.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PSNL Stock
- Valuation Personalis, Inc.
Select your edition
All financial news and data tailored to specific country editions
